Investigators found varying gene expression, biochemical programs in meningiomas challenging current classification criteria, emphasizing the need for personalized treatments based on tumor characteristics.
Meningiomas, although often benign, can exhibit aggressive behavior requiring diverse therapies like radiation, molecular therapy, chemotherapy, or immunotherapy.
[
add
]
[
|
|
...
]